Buradasınız

Anasayfa » Content

Erken Evre Meme Kanserlerinde Aksiller Sentinel Lenf Nodlarının Lenfosintigrafi ve İntraoperatuar Gama Prob İle Saptanması

Lymphoscintigraphic And Intraoperative Gamma Probe Detection of Sentinel Lymph Nodes in Early Stage Breast Cancer

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2006

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Sentinel lymph node (SLN) biopsy has been rapidly and widely adopted by the surgical community as a minimally invasive staging procedure, and as an alternative to axillary lymph node dissection for patients with breast cancer. A variety of different techniques have been reported for SLN biopsy in breast cancer. SLN biopsy can be performed using injection of a blue dye, radioactive colloid, or both. When radioactive colloid is used, a number of technical issues as well as other reasons causing false negative results should be taken into account for a successful SLN detection.
Bookmark/Search this post with
Abstract (Original Language): 
Sentinel lenf nodu (SLN) biyopsisi cerrahi dünyasında meme kanserli hastalarda aksiller evreleme için aksiller diseksiyona alternatif minimal invaziv bir yöntem olarak hızlı ve yaygın şekilde kabul görmeye başlamıştır. SLN biyopsisi için pek çok farklı teknikler tarif edilmiş olup, bu amaçla mavi boya, radyoaktif kolloid veya ikisinin kombine kullanıldığı enjeksiyon yöntemleri mevcuttur. Radyoaktif kolloidin kullanılacağı durumlarda, başarılı bir SLN deteksiyonu için, uygulama açısından bazı teknik detayların iyi bilinmesinin yanında yalancı negatifliğe yol açan diğer faktörlerin de dikkate alınması gerekmektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-erken-evre-meme-kanserlerinde-aksiller-sentinel-lenf-nodlarinin-lenfosintigrafi-intraoperatuar-gama-prob-ile-saptanmasi.pdf
  • 3
109-112
  • Turkish

REFERENCES

References: 

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004.
CA Cancer J Clin 2004; 54:8-29.
2. Morrow M, Foster RS. Staging of breast cancer. A new
rationale for internal mammary node biopsy. Arch Surg
1981;166:748–51.
3. Veronesi U, Cascinelli N, Greco M et al. Prognosis of breast
cancer patients after mastectomy and dissection of internal
mammary nodes. Ann Surg 1985;202: 702–7
4. Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I,
Mizukami Y. Reappraisal of internal mammary node
metastases as a prognostic factor on patients with breast
cancer. Cancer 1991;68:1918–25
5. Gradishar WJ. The future of breast cancer: the role of
prognostic factors. Breast Cancer Res Treat 2005;89 Suppl
1:S17-26.
6. Veronesi U, Paganelli G, Viale G, et al. A randomized
comparison of sentinel-node biopsy with routine axillary
dissection in breast cancer. N Engl J Med 2003;349:546–53.
7. Morton DL, Thompson JF, Essner R, et al. Validation of the
accuracy of intraoperative lymphatic mapping and sentinel
lymphadenectomy for early-stage melanoma: A multicenter
trial-Multicenter Selective Lymphadenectomy Trial Group.
Ann Surg 1999;230:453–65.
8. Jakub JW, Pendas S, Reintgen DS. Current Status of Sentinel
Lymph Node Mapping and Biopsy: Facts and Controversies.
The Oncologist 2003;8:59–68.
9. Trifirò G, Viale G, Gentilini O, Travaini LL, Paganelli G.
Sentinel node detection in pre-operative axillary staging. Eur
J Nucl Med Mol Imaging (2004) 31 (Suppl. 1): S46–S55.
10. Schwartz GF, Giuliano AE, Veronesi U (Consensus
Conference Committee). Proceedings of the consensus
conference on the role of sentinel lymph node biopsy in
carcinoma of the breast. April 19–22, 2001, Philadelphia,
Pennsylvania. Cancer 2002;94:2542–51.
11. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br
J Surg 2002;89:21–34.
12. Cox CE, Bass SS, McCann CR, et al. Lymphatic mapping and
sentinel lymph node biopsy in patients with breast cancer.
Annu Rev Med 200;51:525-42.
13. Cody HS 3rd, Fey J, Akhurst T et al. Complementarity of
blue dye and isotope in sentinel node localization for breast
cancer: univariate and multivariate analysis of 966 procedures.
Ann Surg Oncol 2001;8:13–9.
14. Noguchi M, Motomura K, Imoto S et al. A multicenter
validation study of sentinel lymph node biopsy by the
Japanese Breast Cancer Society. Breast Cancer Res Treat
2000;63:31–40.
15. Kim T, Giuliano AE, Lyman GH. Lymphatic Mapping and
Sentinel Lymph Node Biopsy in Early-Stage Breast
Carcinoma- A Metaanalysis. Cancer 2006;106:4–16.
16. Vijayakumara V, Boernerb PS, Janic AB, Vijayakumarb S. A
critical review of variables affecting the accuracy and falsenegative rate of sentinel node biopsy procedures in early
breast cancer. Nucl Med Commun 2005;26:395–405.
17. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel
lymph node biopsy in breast cancer surgery. J Nucl Med
2001; 42:1198–215.
18. Aarsvold JN, Alazraki NP. Update on detection of sentinel
lymph nodes in patients with breast cancer. Semin Nucl Med
2005;35:116–28.
19. Krynyckyi BR, Kim CK, Goyenechea MR, Chan PT, Zhang Z,
Machac J. Clinical Breast Lymphoscintigraphy: Optimal A.T. Akpınar, ark.
112
Techniques for Performing Studies, Image Atlas, and
analysis of Images. RadioGraphics 2004; 24:121–45.
20. Alex JC, Krag DN. The gamma-probe-guided resection of
radiolabeled primary lymph nodes. Surg Oncol Clin N Am
1996; 5:33–41.
21. Goyal A, Newcombe RG, Mansel RE. Role of routine
preoperative lymphoscintigraphy in sentinel node biopsy for
breast cancer. Eur J Cancer 2005; 41:238–43.
22. McMasters KM, Wong SL, Tuttle TM et al. Preoperative
lymphoscintigraphy for breast cancer does not improve the
ability to identify axillary sentinel lymph nodes. Ann Surg
2000; 231:724–31.
23. Lyman GH, Giuliano AE, Somerfield MR, et al: American
Society of Clinical Oncology guideline recommendations for
sentinel lymph node biopsy in early-stage breast cancer. J
Clin Oncol 2005;23:7703- 20.

Thank you for copying data from http://www.arastirmax.com